Madigan Catherine 4
4 · Syndax Pharmaceuticals Inc · Filed Mar 3, 2022
Insider Transaction Report
Form 4
Madigan Catherine
Chief Medical Officer
Transactions
- Award
Stock Options (Right to buy)
2022-03-01$16.06/sh+180,000$2,890,800→ 180,000 totalExercise: $16.06Exp: 2032-03-01→ Common Stock (180,000 underlying)
Footnotes (1)
- [F1]Twenty five percent (25%) of the total number of shares underlying the option shall vest on March 1, 2023, and one-thirty-sixth (1/36th) of the remaining shares underlying the option shall vest monthly thereafter on the last day of each month, subject to the reporting person's continuous service on the relevant vesting dates.